HEPATITIS C TREATMENT OF RENAL TRANSPLANT AND CHRONIC KIDNEY DISEASE PATIENTS: EFFICACY AND SAFETY OF DIRECT-ACTING ANTIVIRAL REGIMENS CONTAINING SOFOSBUVIR

Arquivos De Gastroenterologia
Fernanda Bellini Lunardi MichelsMaria Lucia Gomes Ferraz

Abstract

Direct-acting antivirals have revolutionized hepatitis C treatment, also for patients with chronic kidney disease (CKD), but some controversy exists regarding the use of sofosbuvir (SOF) in patients with glomerular filtration rate (GFR) <30 mL/min. To evaluate the efficacy and safety of these regimens for hepatitis C treatment of patients with CKD and after renal transplantation, as well as the impact of SOF on renal function in non-dialysis patients. All patients with hepatitis C and CKD or renal transplant treated with direct-acting antivirals at a referral center in Brazil between January 2016 and August 2017 were included. Efficacy was evaluated based on viral load (HCV RNA) and a sustained virological response (SVR) consisting of undetectable RNA 12 and/or 24 weeks after the end of treatment (SVR12 and SVR24) was defined as cure. Safety was determined by adverse events and ribavirin, when combined, was administered in escalating doses to all patients with GFR <60 mL/min. The impact of SOF on renal function was determined by the measurement of baseline creatinine during and after the end of treatment and its increase was evaluated using the Acute Kidney Injury Network (AKIN) classification. A total of 241 patients (52.7% fe...Continue Reading

References

Dec 16, 2006·Current Medicinal Chemistry·Stefan RussmannGiuseppe Palasciano
May 24, 2014·Transplant International : Official Journal of the European Society for Organ Transplantation·Patrizia BurraMarco Senzolo
Oct 16, 2014·Kidney International·Mark E ThomasMarlies Ostermann
Dec 5, 2014·World Journal of Gastroenterology : WJG·Kaartik Soota, Benedict Maliakkal
Nov 20, 2015·Liver International : Official Journal of the International Association for the Study of the Liver·Hector E NazarioApurva A Modi
Mar 1, 2016·Liver International : Official Journal of the International Association for the Study of the Liver·Varun SaxenaUNKNOWN HCV-TARGET
Apr 22, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Elise J SmoldersDavid M Burger
Nov 24, 2016·Expert Opinion on Drug Safety·Cristina ScavoneAnnalisa Capuano
Dec 13, 2016·Liver International : Official Journal of the International Association for the Study of the Liver·Tao LiLei Wang
Jan 21, 2017·Journal of Viral Hepatitis·M Mendizabal, K R Reddy
Mar 4, 2017·International Journal of General Medicine·Nicholas J BurstowSimon D Taylor-Robinson
Jul 15, 2017·The International Journal of Artificial Organs·Fabrizio FabriziPiergiorgio Messa
Jul 26, 2017·World Journal of Hepatology·Marco LadinoDavid Roth
Sep 9, 2017·Clinical Journal of the American Society of Nephrology : CJASN·Meghan E SiseRaymond T Chung
Oct 29, 2017·International Journal of Clinical Pharmacy·Thalia MedeirosAndrea Alice da Silva
Jan 30, 2018·Journal of Viral Hepatitis·M J Álvarez-OssorioUNKNOWN HEPAVIR-DAA, GEHEP-MONO, RIS-HEP07 and RIS-HEP13 Study Groups
Feb 11, 2018·Liver International : Official Journal of the International Association for the Study of the Liver·Stanislas Pol, Lucia Parlati
May 8, 2018·Journal of Clinical Pharmacy and Therapeutics·T MedeirosJ R Almeida
May 18, 2018·BMC Infectious Diseases·Simone LaniniUNKNOWN members of the Lazio Region HCV treatment group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.